000			01809 a2200469 4500
005			20250517070832.0
264		0	_c20160928
008			201609s 0 0 eng d
022			_a1846-9558
024	7		_a10.1515/acph-2015-0034 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuang, Zhiwei
245	0	0	_aInduction of cell cycle arrest via the p21, p27-cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol. _h[electronic resource]
260			_bActa pharmaceutica (Zagreb, Croatia) _cDec 2015
300			_a463-71 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCarcinoma, Hepatocellular _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aClioquinol _xpharmacology
650	0	4	_aCyclin A2 _xgenetics
650	0	4	_aCyclin E _xgenetics
650	0	4	_aCyclin-Dependent Kinase 2 _xgenetics
650	0	4	_aCyclin-Dependent Kinase Inhibitor p21 _xgenetics
650	0	4	_aCyclin-Dependent Kinase Inhibitor p27 _xgenetics
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aGene Expression Regulation, Enzymologic
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aOncogene Proteins _xgenetics
650	0	4	_aS Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTime Factors
700	1		_aWang, Lianqiu
700	1		_aChen, Lifeng
700	1		_aZhang, Yifei
700	1		_aShi, Ping
773	0		_tActa pharmaceutica (Zagreb, Croatia) _gvol. 65 _gno. 4 _gp. 463-71
856	4	0	_uhttps://doi.org/10.1515/acph-2015-0034 _zAvailable from publisher's website
999			_c25551375 _d25551375